Nath Bio-Genes (I)

Nath Bio-Genes (I) EBIT

The EBIT of Nath Bio-Genes (I) (NATHBIOGEN.NS) as of Nov 10, 2026 is 484.75 M INR. In the previous year, EBIT was 459.82 M INR — a change of 5.42% (higher).

EBIT

484.75 MINR

YoY

5.42%

Last updated:

In 2026, Nath Bio-Genes (I)'s EBIT was 484.75 M INR, a 5.42% increase from the 459.82 M INR EBIT recorded in the previous year.

The Nath Bio-Genes (I) EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2023
464.39 M INR
Jan 1, 2024
477.02 M INR
Jan 1, 2025
459.82 M INR
Jan 1, 2026
484.75 M INR
Jan 1, 2027 (e)
770.68 M INR
Jan 1, 2028 (e)
793.79 M INR
Jan 1, 2029 (e)
867.13 M INR
Jan 1, 2030 (e)
963.58 M INR
The Nath Bio-Genes (I) EBIT history
YEAREBITYoY
est963.58 MINR+11.12%
est867.13 MINR+9.24%
est793.79 MINR+3.00%
est770.68 MINR+58.99%
484.75 MINR+5.42%
459.82 MINR-3.61%
477.02 MINR+2.72%
464.39 MINR-66.25%
1.38 BINR+110.94%
652.34 MINR+22.24%
533.65 MINR+27.08%
419.92 MINR+1.19%
414.99 MINR+14.77%
361.59 MINR+68.54%
214.55 MINR-29.65%
304.98 MINR+19.54%
255.13 MINR+107.49%
122.96 MINR+35.49%
90.75 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nath Bio-Genes (I) Revenue

Nath Bio-Genes (I) Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
3.01 B INR
464.39 M INR
350.11 M INR
Jan 1, 2024
2.48 B INR
477.02 M INR
396.19 M INR
Jan 1, 2025
3.65 B INR
459.82 M INR
386.00 M INR
Jan 1, 2026
4.45 B INR
484.75 M INR
416.30 M INR
Jan 1, 2027 (e)
2.41 B INR
770.68 M INR
494.00 M INR
Jan 1, 2028 (e)
2.79 B INR
793.79 M INR
511.48 M INR
Jan 1, 2029 (e)
3.33 B INR
867.13 M INR
566.96 M INR
Jan 1, 2030 (e)
3.83 B INR
963.58 M INR
639.92 M INR

Nath Bio-Genes (I) Margins

Nath Bio-Genes (I) stock margins

The Nath Bio-Genes (I) margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Nath Bio-Genes (I). The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Nath Bio-Genes (I).
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
55.33 %
15.41 %
11.62 %
Jan 1, 2024
41.66 %
19.27 %
16.01 %
Jan 1, 2025
62.85 %
12.60 %
10.58 %
Jan 1, 2026
45.80 %
10.89 %
9.35 %
Jan 1, 2027 (e)
45.80 %
32.00 %
20.51 %
Jan 1, 2028 (e)
45.80 %
28.43 %
18.32 %
Jan 1, 2029 (e)
45.80 %
26.03 %
17.02 %
Jan 1, 2030 (e)
45.80 %
25.16 %
16.71 %

Nath Bio-Genes (I) Stock analysis

What does Nath Bio-Genes (I) do? Nath Bio-Genes (I) Ltd. generates revenue through the production and marketing of seeds across multiple categories including oilseeds and fiber, field crops, vegetables, and plant nutrition. The company's oilseeds and fiber products feature cotton and mustard, while its vegetable crop range includes chili, okra, tomato, bottle gourd, bitter gourd, cucumber, coriander, pumpkin, tinda, and others. Field crops such as corn, jowar, hybrid paddy, research paddy, and wheat are also part of its offerings. Plant nutrition products like WINPro GOLii, WINall, and Win Chin Win, along with forage products NUTRIMAX and NUTRIMAX GOLD, contribute to its revenue streams. The company operates seed processing facilities in Maharashtra, Telangana, and Andhra Pradesh, with additional processing arrangements in Gujarat, Karnataka, Tamil Nadu, Madhya Pradesh, and Rajasthan on a custom basis. The primary buyers of Nath Bio-Genes' products are farmers and agricultural businesses across India, particularly in regions where the company maintains processing facilities and custom processing arrangements. The firm's seed cultivation segment targets a broad agricultural market, focusing on staple crops and high-demand vegetables. Its plant nutrition and forage product lines cater to specialized farming needs, enhancing crop yield and livestock feed quality. The company's product portfolio is designed to meet the diverse requirements of Indian farmers, from traditional oilseed cultivation to modern vegetable farming practices. Nath Bio-Genes' revenue is derived from the sale of seed varieties and plant nutrition products to agricultural stakeholders in key Indian states. The company's processing facilities in Maharashtra, Telangana, and Andhra Pradesh serve as central hubs for seed production and distribution, while custom processing partnerships in other states extend its market reach. The firm's product categories, including cotton, mustard, chili, tomato, corn, and WINPro GOLii, are marketed directly to farmers and agricultural cooperatives, ensuring consistent demand across different crop cycles and seasons. Nath Bio-Genes (I) is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Nath Bio-Genes (I)'s EBIT

Nath Bio-Genes (I)'s Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Nath Bio-Genes (I)'s EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Nath Bio-Genes (I)'s EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Nath Bio-Genes (I)’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Nath Bio-Genes (I) stock

EBIT of Nath Bio-Genes (I) is 484.75 M INR in 2026.

EBIT of Nath Bio-Genes (I) changed from 459.82 M INR to 484.75 M INR, representing a 5.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Nath Bio-Genes (I) since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Nath Bio-Genes (I) historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Nath Bio-Genes (I)

All Key Metrics — Nath Bio-Genes (I)